193 related articles for article (PubMed ID: 30700767)
1. Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations.
Dash S; Kinney NA; Varghese RT; Garner HR; Feng WC; Anandakrishnan R
Sci Rep; 2019 Jan; 9(1):1005. PubMed ID: 30700767
[TBL] [Abstract][Full Text] [Related]
2. Identifying multi-hit carcinogenic gene combinations: Scaling up a weighted set cover algorithm using compressed binary matrix representation on a GPU.
Al Hajri Q; Dash S; Feng WC; Garner HR; Anandakrishnan R
Sci Rep; 2020 Feb; 10(1):2022. PubMed ID: 32029803
[TBL] [Abstract][Full Text] [Related]
3. Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations.
Anandakrishnan R; Varghese RT; Kinney NA; Garner HR
PLoS Comput Biol; 2019 Mar; 15(3):e1006881. PubMed ID: 30845172
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous identification of multiple driver pathways in cancer.
Leiserson MD; Blokh D; Sharan R; Raphael BJ
PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
[TBL] [Abstract][Full Text] [Related]
5. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
7. Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Wang Z; Ng KS; Chen T; Kim TB; Wang F; Shaw K; Scott KL; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2018; 13(5):e0196939. PubMed ID: 29738578
[TBL] [Abstract][Full Text] [Related]
8. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
9. CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model.
Zhao W; Yang J; Wu J; Cai G; Zhang Y; Haltom J; Su W; Dong MJ; Chen S; Wu J; Zhou Z; Gu X
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876217
[TBL] [Abstract][Full Text] [Related]
10. VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.
Jia P; Zhao Z
PLoS Comput Biol; 2014 Feb; 10(2):e1003460. PubMed ID: 24516372
[TBL] [Abstract][Full Text] [Related]
11. Identifying modules of cooperating cancer drivers.
Klein MI; Cannataro VL; Townsend JP; Newman S; Stern DF; Zhao H
Mol Syst Biol; 2021 Mar; 17(3):e9810. PubMed ID: 33769711
[TBL] [Abstract][Full Text] [Related]
12. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
13. A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
Zhang N; Ma F; Guo D; Pang Y; Wang C; Zhang Y; Zheng X; Wang M
PLoS Comput Biol; 2024 Apr; 20(4):e1012068. PubMed ID: 38683860
[TBL] [Abstract][Full Text] [Related]
14. CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers.
Tokheim C; Karchin R
Cell Syst; 2019 Jul; 9(1):9-23.e8. PubMed ID: 31202631
[TBL] [Abstract][Full Text] [Related]
15. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
Zhang J; Zhang S
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
[TBL] [Abstract][Full Text] [Related]
16. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
17. Identification of cancer driver genes based on nucleotide context.
Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
[TBL] [Abstract][Full Text] [Related]
18. Discovery of mutated subnetworks associated with clinical data in cancer.
Vandin F; Clay P; Upfal E; Raphael BJ
Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
[TBL] [Abstract][Full Text] [Related]
19. Identifying tumorigenic non-coding mutations through altered
Cheng Z; Vermeulen M; Rollins-Green M; Babak T; DeVeale B
STAR Protoc; 2021 Dec; 2(4):100934. PubMed ID: 34816127
[TBL] [Abstract][Full Text] [Related]
20. Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO.
Lee G; Liang JW; Zhang Q; Huang T; Choirat C; Parmigiani G; Braun D
Elife; 2021 Aug; 10():. PubMed ID: 34406119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
